Congratulations to Takeda UK and Makara Health on their recognition at the PMEA Awards 30 Nov 2020

PharmaMedic was delighted to support and sponsor the Excellence in Rare Diseases and Orphan Drugs category at the recent PMEA Awards.  Naturally, the ceremony had to take place virtually this year.  Nevertheless, we found this to be an inspiring event showcasing innovation and collaborations from around the industry.

On the night, the accolade for the Excellence in Rare Diseases and Orphan Drugs category went to Takeda UK with support from Makara Health for their work in Hereditary Angioedema.  Hereditary angioedema is a severe and debilitating disorder, and the partnership’s important contributions in this area are vital for the patients around the world suffering from this condition.  We were delighted to have the opportunity to showcase Takeda UK’s achievements in this critical indication along with the work of the other shortlisted entries from Sobi Inc and Sanofi Genzyme.  At PharmaMedic, we fully share these organisations’ passion for translating scientific excellence in rare diseases into stakeholder value and bringing new medicines to the patients who need them.

Did you miss the awards ceremony?  Click here to watch the event recording.

For the PMEA 2020 results brochure please click here.